Empirical Finance LLC lifted its holdings in Tenet Healthcare Co. (NYSE:THC - Free Report) by 69.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,360 shares of the company's stock after buying an additional 3,414 shares during the period. Empirical Finance LLC's holdings in Tenet Healthcare were worth $1,055,000 as of its most recent SEC filing.
Several other large investors have also recently bought and sold shares of THC. New Wave Wealth Advisors LLC acquired a new position in shares of Tenet Healthcare in the 4th quarter valued at about $343,000. Swedbank AB lifted its position in Tenet Healthcare by 100.0% in the 4th quarter. Swedbank AB now owns 40,000 shares of the company's stock worth $5,049,000 after buying an additional 20,000 shares in the last quarter. Legacy Capital Group California Inc. purchased a new position in shares of Tenet Healthcare during the 3rd quarter valued at $1,055,000. Signet Financial Management LLC purchased a new stake in shares of Tenet Healthcare during the fourth quarter worth $1,526,000. Finally, Intech Investment Management LLC grew its stake in Tenet Healthcare by 44.4% in the third quarter. Intech Investment Management LLC now owns 79,266 shares of the company's stock valued at $13,174,000 after purchasing an additional 24,385 shares in the last quarter. 95.44% of the stock is owned by institutional investors and hedge funds.
Several equities research analysts have recently issued reports on the company. UBS Group lifted their price target on Tenet Healthcare from $197.00 to $217.00 and gave the company a "buy" rating in a report on Wednesday, October 30th. Royal Bank of Canada increased their price target on shares of Tenet Healthcare from $174.00 to $183.00 and gave the stock an "outperform" rating in a research note on Wednesday, October 30th. StockNews.com cut shares of Tenet Healthcare from a "strong-buy" rating to a "buy" rating in a report on Tuesday, December 17th. Truist Financial reduced their price target on Tenet Healthcare from $190.00 to $175.00 and set a "buy" rating for the company in a research report on Monday, January 6th. Finally, KeyCorp cut their price objective on Tenet Healthcare from $200.00 to $185.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 7th. Three analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Tenet Healthcare currently has a consensus rating of "Moderate Buy" and a consensus price target of $165.00.
View Our Latest Stock Analysis on THC
NYSE THC opened at $139.61 on Tuesday. Tenet Healthcare Co. has a twelve month low of $86.90 and a twelve month high of $171.20. The company has a debt-to-equity ratio of 2.35, a quick ratio of 1.52 and a current ratio of 1.58. The stock has a market cap of $13.28 billion, a PE ratio of 4.47, a PEG ratio of 0.63 and a beta of 2.05. The firm has a 50-day simple moving average of $133.91 and a 200 day simple moving average of $148.62.
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you make your next trade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.
They believe these five stocks are the five best companies for investors to buy now...
See The Five Stocks Here
Before you consider Tenet Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tenet Healthcare wasn't on the list.
While Tenet Healthcare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.